Cargando…
Dabigatran in Secondary Stroke Prevention: Clinical Experience with 106 Patients
Introduction. Our aim was to analyze our clinical experience with dabigatran etexilate in secondary stroke prevention. Methods. We retrospectively included patients starting dabigatran etexilate for secondary stroke prevention from March 2010 to December 2012. Efficacy and safety variables were regi...
Autores principales: | DeFelipe-Mimbrera, Alicia, Cánovas, Araceli Alonso, Guillán, Marta, Matute, Consuelo, Sainz de la Maza, Susana, Cruz, Antonio, Vera, Rocío, Masjuan, Jaime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123474/ https://www.ncbi.nlm.nih.gov/pubmed/25133166 http://dx.doi.org/10.1155/2014/567026 |
Ejemplares similares
-
Use of the Cardiovascular Polypill in Secondary Prevention of Cerebrovascular Disease: A Real-Life Tertiary Hospital Cohort Study of 104 Patients
por: Ros-Castelló, Victoria, et al.
Publicado: (2020) -
Quality of Chronic Anticoagulation Control in Patients with Intracranial Haemorrhage due to Vitamin K Antagonists
por: Estevez-Fraga, Carlos, et al.
Publicado: (2018) -
High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study
por: Monreal, Enric, et al.
Publicado: (2020) -
Features of Pharmacodynamics of the Anticoagulant Dabigatran in Secondary
Thrombophilia
por: Kairov, Gaisa T., et al.
Publicado: (2018) -
Dabigatran Acylglucuronide, the Major Metabolite of Dabigatran, Shows a Weaker Anticoagulant Effect than Dabigatran
por: Kim, Jong-Min, et al.
Publicado: (2022)